Abstract—Obesity is one of the major challenges in modern society. More than a third of the world’s population suffers froms overweight. This phenotype affects the quality of life and is associated with cardiovascular diseases, diabetes, cancer and reproductive disorders. The population variability of allele frequencies of 26 single nucleotide polymorphisms, in association with obesity and body mass index, according to data from genome-wide association studies (GWASs) is discussed in this study. Genetic variability was analyzed in populations of Northern Eurasia and populations from the human genome diversity project (HGDP). The population samples are characterized by high genetic diversity that correlates with climatic and geographical parameters. The results of the test for searching for natural selection signals revealed a selection effect for rs1167827 of the HIP1 gene, rs7138803 and rs7164727 located in the intergenic region, rs7141420 of the NRXN3 gene, rs7498665 of the SH2B1 gene, and rs7903146 of the TCF7L2 gene.
Similar content being viewed by others
REFERENCES
Boden G. 2008. Obesity and free fatty acids. Endocrinol. Metab. Clin. North Am. 37 (3), 635–646.
Turula M., Kaprio J., Rissanen A., Koskenvuo M. 1990. Body weight in the Finnish Twin Cohort. Diabetes Res. Clin. Pract. 10, S33–S36.
Wardle J., Carnell S., Haworth C.M., Plomin R. 2008. Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment. Am. J. Clin. Nutr.87, 398–404.
GWAS Catalog. https://www.ebi.ac.uk/gwas/ Accessed September 20, 2018.
Neel J.V. 1999. The “thrifty genotype” in 1998. Nutr. Rev. 57, S2–S9.
Speakman J.R. 2008. Thrifty genes for obesity, an attractive but flawed idea, and an alternative perspective: The “drifty gene” hypothesis. Int. J. Obes. (Lond.). 32, 1611–1617.
Sellayah D., Cagampang F.R., Cox R.D. 2014. On the evolutionary origins of obesity: A new hypothesis. Endocrinology. 155, 1573–1588.
Berndt S.I., Gustafsson S., Mägi R.; GIANT Consortium. 2013. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat. Genet. 45, 501–512.
Locke A.E., Kahali B., Berndt S.I.; GIANT Consortium. 2015. Genetic studies of body mass index yield new insights for obesity biology. Nature. 518, 197–206.
Felix J.F., Bradfield J.P., Monnereau C.; GIANT Consortium. 2016. Genome-wide association analysis identifies three new susceptibility loci for childhood body mass index. Hum. Mol. Genet. 25, 389–403.
Justice A.E., Winkler T.W., Feitosa M.F.; GIANT Consortium. 2017. Genome-wide meta-analysis of 241 258 adults accounting for smoking behaviour identifies novel loci for obesity traits. Nat. Commun. 8, 14977.
Akiyama M., Okada Y., Kanai M.; GIANT Consortium. 2017. Genome-wide association study identifies 112 new loci for body mass index in the Japanese population. Nat. Genet. 49, 1458–1467.
Graff M., Scott R.A., Justice A.E.; GIANT Consortium. 2017. Genome-wide physical activity interactions in adiposit: A meta-analysis of 200452 adults. PLoS Genet. 13, e1006528.
Warrington N.M., Howe L.D., Paternoster L.; GIANT Consortium. 2015. A genome-wide association study of body mass index across early life and childhood. Int. J. Epidemiol. 44, 700–712.
Speliotes E.K., Willer C.J., Berndt S.I.; GIANT Consortium. 2010. Association analyses of 249 796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 42, 937–948.
Graff M., Ngwa J.S., Workalemahu T., Homuth G., Schipf S., Teumer A., Völzke H., Wallaschofski H., Abecasis G.R., Edward L., Francesco C., Sanna S., Scheet P., Schlessinger D., Sidore C., et al. 2013. Genome-wide analysis of BMI in adolescents and young adults reveals additional insight into the effects of genetic loci over the life course. Hum. Mol. Genet. 22, 3597–3607.
Wen W., Zheng W., Okada Y.; GIANT Consortium. 2014. Meta-analysis of genome-wide association studies in East Asian-ancestry populations identifies four new loci for body mass index. Hum. Mol. Genet. 23, 5492–5504.
Thorleifsson G., Walters G.B., Gudbjartsson D.F., Steinthorsdottir V., Sulem P., Helgadottir A., Styrkarsdottir U., Gretarsdottir S., Thorlacius S., Jonsdottir I., Jonsdottir T., Olafsdottir E.J., Olafsdottir G.H., Jonsson T., Jonsson F., et al. 2009. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat. Genet. 41, 18–24.
Wheeler E., Huang N., Bochukova E.G., Keogh J.M., Lindsay S., Garg S., Henning E., Blackburn H., Loos R.J., Wareham N.J., O’Rahilly S., Hurles M.E., Barroso I., Farooqi I.S. 2013. Genome-wide SNP and CNV analysis identifies common and low-frequency variants associated with severe early-onset obesity. Nat. Genet. 45, 513–517.
Comuzzie A.G., Cole S.A., Laston S.L., Voruganti V.S., Haack K., Gibbs R.A., Butte N.F. 2012. Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population. PLoS One. 7, e51954.
Willer C.J., Speliotes E.K., Loos R.J.; GIANT Consortium. 2009. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat. Genet. 41 (1), 25–34.
Ng M.C.Y., Graff M., Lu Y.; GIANT Consortium. 2017. Discovery and fine-mapping of adiposity loci using high density imputation of genome-wide association studies in individuals of African ancestry: African Ancestry Anthropometry Genetics Consortium. PLoS Genet. 13, e1006719.
Namjou B., Keddache M., Marsolo K., Wagner M., Lingren T., Cobb B., Perry C., Kennebeck S., Holm I.A., Li R., Crimmins N.A., Martin L., Solti I., Kohane I.S., Harley J.B. 2013. EMR-linked GWAS study: investigation of variation landscape of loci for body mass index in children. Front. Genet. 4, 268.
Cotsapas C., Speliotes E.K., Hatoum I.J., Greenawalt D.M., Dobrin R., Lum P.Y., Suver C., Chudin E., Kemp D., Reitman M., Voight B.F., Neale B.M., Schadt E.E., Hirschhorn J.N., Kaplan L.M., Daly M.J.; GIANT Consortium. 2009. Common body mass index-associated variants confer risk of extreme obesity. Hum. Mol. Genet. 18, 3502–3507.
Stepanov V.A., Trifonova E.A. 2013. Multiplex SNP genotyping by MALDI-TOF mass spectrometry: Frequencies of 56 immune response gene SNPs in human populations. Mol. Biol. (Moscow). 47 (6), 852–862.
Weatherbase. https://www.weatherbase.com/ Accessed December 2, 2018.
https://www.rosminzdrav.ru/ministry/61/22/stranitsa-979/ statisticheskie-informatsionnye-materialy/statisticheskiy-sbornik-2017-god. Accessed November 20, 2018.
World Health Organization. https://www.who.int/ru Accessed November 17, 2018.
Arlequin ver 3.5.2.2. http://cmpg.unibe.ch/software/ arlequin35/ Accessed November 2, 2018.
String. https://string-db.org/ Accessed July 1, 2019.
WEB-Based Gene Set Analysis Toolkit. http:// www.webgestalt.org/ Accessed July 1, 2019.
Stepanov V.A. 2016. Evolution of genetic diversity and human diseases. Russ. J. Genet.52 (7), 746–756.
Stepanov V.A., Kharkov V.N., Vagaitseva K.V., Bocharova A.V., Kazantsev A.Yu., Popovich A.A., Khitrinskaya I.Yu. 2017. Search for genetic markers of climatic adaptation in populations of North Eurasia. Russ. J. Genet.53 (11), 1172–1183.
Stepanov V.A., Candelaria P., Khoo S., Zhang G., Trifonova E.A., Simonova K.V., Bocharova A.V., Laing I.A., Hayden C., Backer V., Bjerregaard P., Lynch N., Hagel I., Musk A.W., Bittles A., et al. 2013. Immune response decanalization in the resettlement of modern humans: The relationship of genetic diversity in the genes of the immune system with climatic and geographical factors. Med. Genet.12, 8–18.
Hanoune J., Defer N. 2001. Regulation and role of adenylyl cyclase isoforms. Annu. Rev. Pharmacol. Toxicol. 41, 145–174.
Lukyanova L.D. 2004. Role of bioenergetic disturbances in the pathogenesis of hypoxia. Patol. Fiziol. Eksp. Terap.2, 2–11.
Levin Yu.M. 2006. Proryv v endoekologicheskuyu meditsinu. Novyi uroven’ vrachebnogo myshleniya i effektivnoi terapii (A Breakthrough toward Endoecologica Medicine: A New Level of Medical Thought and Effective Therapy). Moscow: Shcherbinskaya Tipografiya.
Adeva-Andany M.M., Funcasta-Calderón R., Fernández-Fernández C., Castro-Quintela E., Carneiro-Freire N. 2018. Metabolic effects of glucagon in humans. J. Clin. Transl. Endocrinol. 15, 45–53.
Chesnokova N.P., Mikhailova A.B. 2006. Infektsionnyi protsess (The Infection Process). Moscow: Akademiya Estestvoznaniya.
Parsons P.A. 2005. Environments and evolution: Interactions between stress, resource inadequacy and energetic efficiency. Biol. Rev. Camb. Philos Soc. 80, 589–610.
Butcher R.W., Robison G.A., Hardman J.G., Sutherland E.W. 1968. The role of cyclic AMP in hormone actions. Adv. Enzyme Regul. 6, 357–389.
Johansson H., Gylfe E., Hellman B. 1989. Cyclic AMP raises cytoplasmic calcium in pancreatic alpha 2-cells by mobilizing calcium incorporated in response to glucose. Cell Calcium. 10, 205–211.
Lee J.J., Wedow R., Okbay A.; GIANT Consortium. 2018. Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat. Genet.50, 1112–1121.
Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., Boutin P., Vincent D., Belisle A., Hadjadj S., Balkau B., Heude B., Charpentier G., Hudson T.J., Montpetit A., et al. 2007. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 445, 881–885.
Timpson N.J., Lindgren C.M., Weedon M.N., Randall J., Ouwehand W.H., Strachan D.P., Rayner N.W., Walker M., Hitman G.A., Doney A.S., Palmer C.N., Morris A.D., Hattersley A.T., Zeggini E., Frayling T.M., McCarthy M.I. 2009. Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome-wide association data. Diabetes. 58, 505–510.
Elks C.E., Perry J.R., Sulem P.; GIANT Consortium. 2010. Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat. Genet. 42, 1077‒1085.
Xi B., Takeuchi F., Meirhaeghe A.; Kato N., Chambers J.C., Morris A.P., Cho Y.S., Zhang W., Mohlke K.L., Kooner J.S., Shu X.O., Pan H., Tai E.S., Pan H., Wu J.Y., Zhou D., Chandak G.R.; DIAGRAM Consortium; AGEN-T2D Consortium; SAT2D Consortium. 2014. Associations of genetic variants in/near body mass index-associated genes with type 2 diabetes: A systematic meta-analysis. Clin. Endocrinol. (Oxf.). 81, 702–710.
Bradley S.V., Hyun T.S., Oravecz-Wilson K.I., Li L, Waldorff E.I., Ermilov A.N., Goldstein S.A., Zhang C.X., Drubin D.G., Varela K., Parlow A., Dlugosz A.A., Ross T.S. 2007. Degenerative phenotypes caused by the combined deficiency of murine HIP1 and HIP1r are rescued by human HIP1. Hum. Mol. Genet. 16, 1279–1292.
Bradley S.V., Holland E.C., Liu G.Y., Thomas D., Hyun T.S., Ross T.S. 2007. Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor. Cancer Res. 67, 3609–3615.
Rao D.S., Hyun T.S., Kumar P.D., Mizukami I.F., Rubin M.A., Lucas P.C., Sanda M.G., Ross T.S. 2002. Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival. J. Clin. Invest. 110, 351–360.
Lv W.Q., Zhang X., Zhang Q., He J.Y., Liu H.M., Xia X., Fan K., Zhao Q., Shi X.Z., Zhang W.D., Sun C.Q., Deng H.W. 2017. Novel common variants associated with body mass index and coronary artery disease detected using a pleiotropic cFDR method. J. Mol. Cell Cardiol. 112, 1–7.
Haggerty A.F., Sarwer D.B., Schmitz K.H., Ko E.M., Allison K.C., Chu C.S. 2017. Obesity and endometrial cancer: A lack of knowledge but opportunity for intervention. Nutr. Cancer. 69, 990–995.
Rowen L., Young J., Birditt B., Kaur A., Madan A., Philipps D.L., Qin S., Minx P., Wilson R.K., Hood L., Graveley B.R. 2002. Analysis of the human neurexin genes: Alternative splicing and the generation of protein diversity. Genomics. 79, 587–597.
Lachman H.M., Fann C.S., Bartzis M., Evgrafov O.V., Rosenthal R.N., Nunes E.V., Miner C., Santana M., Gaffney J., Riddick A., Hsu C.L., Knowles J.A. 2007. Genomewide suggestive linkage of opioid dependence to chromosome 14q. Hum. Mol. Genet. 16, 1327–1334.
Kelai S., Maussion G., Noble F., Boni C., Ramoz N., Moalic J.M., Peuchmaur M., Gorwood P., Simonneau M. 2008. Nrxn3 upregulation in the globus pallidus of mice developing cocaine addiction. Neuroreport. 19, 751–755.
Clay S.W., Allen J., Parran T. 2008. A review of addiction. Postgrad. Med. 120, E01–E07.
Rapaka R., Schnur P., Shurtleff D. 2008. Obesity and addiction: Common neurological mechanisms and drug development. Physiol. Behav. 95, 2–9.
O’Brien K.B., O’Shea J.J., Carter-Su C. 2002. SH2-B family members differentially regulate JAK family tyrosine kinases. J. Biol. Chem. 277, 8673–8681.
Zhou Y., Rui L. 2013. Leptin signaling and leptin resistance. Front. Med. 7, 207–222.
Bochukova E.G., Huang N., Keogh J., Henning E., Purmann C., Blaszczyk K., Saeed S., Hamilton-Shield J., Clayton-Smith J., O’Rahilly S., Hurles M.E., Farooqi I.S. 2010. Large, rare chromosomal deletions associated with severe early-onset obesity. Nature. 463, 666–670.
Bachmann-Gagescu R., Mefford H.C., Cowan C., Glew G.M., Hing A.V., Wallace S., Bader P.I., Hamati A., Reitnauer P.J., Smith R., Stockton D.W., Muhle H., Helbig I., Eichler E.E., et al. 2010. Recurrent 200-kb deletions of 16p11.2 that include the SH2B1 gene are associated with developmental delay and obesity. Genet. Med. 12, 641–647.
Sampson M.G., Coughlin C.R., Kaplan P., Conlin L.K., Meyers K.E, Zackai E.H., Spinner N.B., Copelovitch L. 2010. Evidence for a recurrent microdeletion at chromosome 16p11.2 associated with congenital anomalies of the kidney and urinary tract (CAKUT) and Hirschsprung disease. Am. J. Med. Genet. A.152A, 2618–2622.
Grant S.F., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., Helgason A., Stefansson H., Emilsson V., Helgadottir A., Styrkarsdottir U., Magnusson K.P., Walters G.B., Palsdottir E., Jonsdottir T., et al. 2006. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 38, 320–323.
Haupt A., Thamer C., Heni M., Ketterer C., Machann J., Schick F., Machicao F., Stefan N., Claussen C.D., Häring H.U., Fritsche A., Staiger H. 2010. Gene variants of TCF7L2 influence weight loss and body composition during lifestyle intervention in a population at risk for type 2 diabetes. Diabetes. 59, 747–750.
Lopez J.P., Lim R., Cruceanu C., Crapper L., Fasano C., Labonte B., Maussion G., Yang J.P., Yerko V., Vigneault E., El Mestikawy S., Mechawar N., Pavlidis P., Turecki G. 2014. miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment. Nat. Med.20, 764–768.
Du B., Zhang P., Tan Z., Xu J. 2017. MiR-1202 suppresses hepatocellular carcinoma cells migration and invasion by targeting cyclin dependent kinase 14. Biomed. Pharmacother.96, 1246–1252.
Quan Y., Song Q., Wang J., Zhao L., Lv J., Gong S. 2017. MiR-1202 functions as a tumor suppressor in glioma cells by targeting Rab1A. Tumour Biol.39 (4), 1010428317697565. https://doi.org/10.1177/1010428317697565
Botla S.K., Savant S., Jandaghi P., Bauer A.S., Mücke O., Moskalev E.A., Neoptolemos J.P., Costello E., Greenhalf W., Scarpa A., Gaida M.M., Büchler M.W., Strobel O., Hackert T., Giese N.A., et al. 2016. Early epigenetic downregulation of microRNA-192 expression promotes pancreatic cancer progression. Cancer Res.76, 4149–4159.
Ceballos F.C., Joshi P.K., Clark D.W., Ramsay M., Wilson J.F. 2018. Runs of homozygosity: Windows into population history and trait architecture. Nat. Rev. Genet.19, 220–234.
Moon J.M., Capra J.A., Abbot P., Rokas A. 2019. Signatures of recent positive selection in enhancers across 41 human tissues. G3: Genes, Genomes,Genetics.9, 2761–2774.
Choi J.H., Zhong X., McAlpine W., Liao T.C., Zhang D., Fang B., Russell J., Ludwig S., Nair-Gill E., Zhang Z., Wang K.W., Misawa T., Zhan X., Choi M., Wang T., et al. 2019. LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. Science.364, eaau0812.
Liu X., Weidle K., Schröck K., Tönjes A., Schleinitz D., Breitfeld J., Stumvoll M., Böttcher Y., Schöneberg T., Kovacs P. 2015. Signatures of natural selection at the FTO (fat mass and obesity associated) locus in human populations. PLoS One.10, e0117093.
Mao L., Fang Y., Campbell M. Southerland W.M. 2017. Population differentiation in allele frequencies of obesity-associated SNPs. BMC Genomics. 10, 861.
Babenko V., Babenko R., Gamieldien J., Markel A. 2019. FTO haplotyping underlines high obesity risk for European populations. BMC Med. Genomics.12 (Suppl. 2), 46.
Romieu I., Dossus L., Barquera S., Blottière H.M., Franks P.W., Gunter M., Hwalla N., Hursting S.D., Leitzmann M., Margetts B., Nishida C., Potischman N., Seidell J., Stepien M., Wang Y., et al. 2017. Energy balance and obesity: What are the main drivers? Cancer Causes Control. 28, 247–258.
Souza S.A., Silva A.B., Cavalcante U.M.B., Lima C.M.B.L., Souza T.C. 2018. Adult obesity in different countries: An analysis via beta regression models. Cad Saude Publica. 34 (8), e00161417. https://doi.org/10.1590/0102-311X00161417
Dzhumagulova A.S., Polupanov A.G., Khalmatov A.N., Altymysheva A.T., Mamatov A.U., Romanova T.A. 2019. Gender and ethnic features of obesity distribution among resditents of urban and rural areas of Kyrgyzstan (based on the results of the Intrepid Project), Kardio.Vestn. 14, 61–66.
Rosenberg N.A., Kang J.T. 2015. Genetic diversity and societally important disparities. Genetics.201, 1–12.
López S., van Dorp L., Hellenthal G. 2016. Human dispersal out of Africa: A lasting debate. Evol. Bioinform. Online. 11, 57–68.
Hales C.N., Barker D.J., Clark P.M., Cox L.J., Fall C., Osmond C., Winter P.D. 1991. Fetal and infant growth and impaired glucose tolerance at age 64 years. Biol. Med. J.303, 1019–1022.
Portha B., Grandjean V., Movassat J. 2019. Mother or father: Who is in the front line? Mechanisms underlying the non-genomic transmission of obesity/diabetes via the maternal or the paternal line. Nutrients. 11, E233.
ACKNOWLEDGMENTS
The work was carried out at the “Medical Genomics” Center for Collective Use (the Research Institute of Medical Genetics, Tomsk National Research Medical Center).
Funding
The study was supported by the Russian Foundation for Basic Research (project No. 18-04-00758).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
Conflict of interests. The authors declare that they have no conflict of interest.
Statement of compliance with standards of research involving humans as subjects. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants involved in the study.
Additional information
Translated by E. Makeeva
Supplementary material
Rights and permissions
About this article
Cite this article
Trifonova, E.A., Popovich, A.A., Bocharova, A.V. et al. The Role of Natural Selection in the Formation of the Genetic Structure of Populations by SNP Markers in Association with Body Mass Index and Obesity. Mol Biol 54, 349–360 (2020). https://doi.org/10.1134/S0026893320030176
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893320030176